SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Economic analyses of human genetics services: A systematic review
9 references·1 citing·36 second hop
Economic analyses of human genetics services: A systematic review (2005)Economic analyses of human genetics servi…Methods for the Economic Evaluation of Health Care Programmes (2005)Methods for the Economic Eval…The quality of published health economic analyses in digestive diseases: A systematic review and quantitative appraisal (2004)The quality of published heal…HER-2 Testing and Trastuzumab Therapy for Metastatic Breast Cancer: A Cost-Effectiveness Analysis (2004)HER-2 Testing and Trastuzumab…A systematic review of cost-effectiveness analyses of pharmacogenomic interventions (2004)A systematic review of cost-e…Examining the Value and Quality of Health Economic Analyses: Implications of Utilizing the QHES (2003)Examining the Value and Quali…Development and Validation of a Grading System for the Quality of Cost-Effectiveness Studies (2003)Development and Validation of…Guidelines for authors and peer reviewers of economic submissions to the BMJ (1996)Guidelines for authors and pe…Cost-Effectiveness in Health and Medicine (1996)Cost-Effectiveness in Health …Methods for the economic evaluation of health care programmes (1987)Methods for the economic eval…Cost–Effectiveness Analysis in Pharmacogenomics (2010)Cost–Effectiveness Analysis i…Quality of life and pharmacoeconomics in clinical trials (1996)The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration (2001)CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials (2010)Systematic reviews: CRD's guidance for undertaking reviews in health care (2010)Akufo and Ibarapa (1965)STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT (1986)Recommendations of the Panel on Cost-Effectiveness in Health and Medicine (1996)Evidence and Value: Impact on DEcisionMaking – the EVIDEM framework and potential applications (2008)Propuesta de guía para la evaluación económica aplicada a las tecnologías sanitarias (2009)WHO Guide for standardisation of economic evaluations of immunization programmes (2009)Decision Making in Health and Medicine: Integrating Evidence and Values (2001)What Is the Price of Life and Why Doesn't It Increase at the Rate of Inflation? (2003)A Cost-Effectiveness Analysis of Adjuvant Trastuzumab Regimens in Early HER2/neu–Positive Breast Cancer (2007)Cost Effectiveness of Adjuvant Trastuzumab in Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer (2007)Cost‐effectiveness analysis of trastuzumab in the adjuvant setting for treatment of HER2‐positive breast cancer (2007)Good Practice Guidelines for Decision-Analytic Modelling in Health Technology Assessment (2006)Exploring Uncertainty in Cost-Effectiveness Analysis (2008)Meta-Analysis, Decision Analysis, and Cost-Effectiveness Analysis: Methods for Quantitative Synthesis in Medicine (1994)Meta-Analysis, Decision Analysis, and Cost-Effectiveness Analysis (1999)A Comparison of Cost Effectiveness Using Data from Randomized Trials or Actual Clinical Practice: Selective Cox-2 Inhibitors as an Example (2009)A systematic review of cost-effectiveness of monoclonal antibodies for metastatic colorectal cancer (2013)Cost-Effectiveness Analyses in Orthopaedic Sports Medicine (2014)Searching Literature Databases for Health Care Economic Evaluations (2002)Current Methodological Issues in the Economic Assessment of Personalized Medicine (2013)Is Individualized Medicine More Cost-Effective? A Systematic Review (2014)The economic case for precision medicine (2018)Assessing the quality of reports of randomized clinical trials: Is blinding necessary? (1996)Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? (1998)Health economics in the field of osteoarthritis: An Expert's consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) (2013)Cost-effectiveness evidence of mental health prevention and promotion interventions: A systematic review of economic evaluations (2021)EQ-SD: a measure of health status from the EuroQol Group (2001)Innovation in the pharmaceutical industry: New estimates of R&D costs (2016)Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses (2016)The estimation of a preference-based measure of health from the SF-36 (2002)Measurement of health state utilities for economic appraisal (1986)The Estimation of a Preference-Based Measure of Health From the SF-12 (2004)
this work references cited by second hop

References

  • 2005Methods for the Economic Evaluation of Health Care Programmes13,647 cited
  • 1996Cost-Effectiveness in Health and Medicine7,192 cited
  • 1987Methods for the economic evaluation of health care programmes4,318 cited
  • 1996Guidelines for authors and peer reviewers of economic submissions to the BMJ1,828 cited
  • 2003Examining the Value and Quality of Health Economic Analyses: Implications of Utilizing the QHES365 cited
  • 2003Development and Validation of a Grading System for the Quality of Cost-Effectiveness Studies311 cited
  • 2004HER-2 Testing and Trastuzumab Therapy for Metastatic Breast Cancer: A Cost-Effectiveness Analysis230 cited
  • 2004The quality of published health economic analyses in digestive diseases: A systematic review and quantitative appraisal95 cited
  • 2004A systematic review of cost-effectiveness analyses of pharmacogenomic interventions95 cited

Cited by

  • 2010Cost–Effectiveness Analysis in Pharmacogenomics53 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work